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Abstract  Introduction: Diabetes-induced vestibular dysfunction has been commonly reported, and asymptomatic 
patients with type 2 diabetes display higher degrees of perceptual visual dependence for spatial orientation than healthy 
controls. This study aims to assess whether HbA1c can predict such visual dependence in the diabetic patients. Methods and 
Materials: Diabetic patients were divided into 2 groups: 22 subjects with “good” (HbA1c < 7%) and 25 with “poor” (HbA1c ≥ 
7%) glycemic control. Otolithic vestibular function was tested using the computerized rod-and-frame test (CRFT) and results 
for the two diabetic groups were compared to 29 healthy controls. Results: When the frame was tilted, the diabetic group 
with “good” glycemic control had largest positioning errors, with a significant difference only in comparison to the control 
group. The “good” glycemic group exhibited larger degree of asymmetry under titled frame condition. Although HbA1c was 
not associated with vestibular asymmetry in any diabetic group, it was significantly associated with visual dependence in the 
“good” glycemic group. During frame tilts, 10 diabetic patients had positioning errors above the reference range of 3.3°, 8 of 
which belonged to the “good” glycemic diabetic group. Conclusions: Diabetes disease processes may affect vestibular 
symmetry during visuo-vestibular conflicts, even in asymptomatic diabetics within the recommended glycemic range. The 
weak correlations between HbA1c and CRFT parameters may indicate that HbA1c cannot fully predict visual dependence or 
asymmetry on the CRFT in patients with diabetes, and different glycemic disorders may affect vestibular dependent spatial 
orientation in diabetic patients. 
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1. Introduction 
Disease processes of diabetes compromising one side 
more than the other may result in vestibular dysfunction 
asymmetry creating a tonic discharge imbalance within the 
vestibular system. Normally any asymmetry of responses is 
reduced by recalibration of vestibular inputs by regulatory 
long term central compensatory mechanisms [1, 2]. Recent 
studies [3-5] have confirmed vestibular dysfunction and 
more specifically subclinical changes in vestibular function 
in patients with Type 2 diabetes mellitus as a newly defined 
diabetes-related complication. These changes have been 
attributed to  microvascular changes  and microangiopathy  
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that can lead to generalized vestibulotoxicity due to ischemia 
of vestibular structures [6-8]. Parkash and Sumati (2013) 
reported that even at the earlier stages of diabetes (less than 4 
years), 31% of patients had subclinical vestibular 
dysfunction as measured by electronystamography (ENG) 
testing [4].  
Subjective visual vertical (SVV) testing assesses spatial 
orientation via vertical perception through evaluating a 
subject’s ability to position a line to vertical position without 
a vertical reference. The ability to normally deviate within ± 
2° from gravitational vertical by most people [9-11] relies on 
the integration of visual and vestibular, mainly otolithic, 
inputs centrally in the brain [12]. Visual dependence, or the 
effect of visual cues on perception of vertical, is tested by 
introducing a frame around the rod. Under normal conditions 
of testing, a tilted surrounding frame distracts the subjects 
and acts as an inaccurate visual cue for vertical perception, 
evoking a rod and frame effect (RFE) in the direction of the 
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tilted frame in healthy individuals. 
A previous study [13] using the same subject population 
as the current study, assessed the spatial cognitive 
dysfunction (disorientation) that may occur with vestibular 
disorders in Type 2 diabetic patients without peripheral 
neuropathy by using the computerized rod and frame test 
(CRFT) to measure perception of vertical. Findings indicated 
greater magnitude and asymmetry of visual dependence in 
diabetic patients during visuo-vestibular conflict compared 
to healthy age-matched controls.  
Given that diabetics have different levels of glycemic 
control, it is expected that patients with poor glycemic 
control will have greater microvascular complications of 
Type 2 diabetes, since a 1% rise in glycosylated 
haemoglobin (HbA1c) levels is associated with a 37% 
increase in microvascular disease [14]. This may be 
extended to the vestibular complications associated with 
Type 2 diabetes, and one would expect greater odds or levels 
of vestibular dysfunction in diabetics with higher HbA1c 
levels. In fact, this was validated by Agrawal’s study [15] 
which reported diabetics with serum HbA1c levels of 7.0% or 
greater to have a higher prevalence of vestibular dysfunction 
with higher HbA1c levels significantly increasing the odds of 
vestibular dysfunction by 60% in age-adjusted analyses. 
Thus glycemic control level may predict the degree of 
subclinical vestibular dysfunction. Our theory is that 
diabetics with poorer glycemic control may have a greater 
level of vestibular dysfunction, and their level of dependence 
on visual input may be enhanced, increasing verticality 
perception errors during visuo-vestibular conflicts. Using 
identical patient data as the previous study by Abdul Razzak 
et al [13], the current study aims to investigate the level of 
visual dependence healthy controls and in patients with Type 
2 diabetes with different levels of glycemic control. Whether 
HbA1c level can predict vestibular asymmetry effects in 
diabetic patients will also be explored. 
2. Methods and Materials 
Subjects  
29 asymptomatic healthy participants (20M and 9F; mean 
age = 56.64 ± 5.45 years), and 47 patients (34M and 13F; 
mean age = 57.0 ± 6.10 years) diagnosed with type 2 diabetes 
mellitus at the Gulf Diabetes Specialist Center in Bahrain 
volunteered for this study. The diabetic patients were then 
divided into two groups according to HbA1c level; 22 
patients with “good” glycemic control (HBA1c < 7% (53 
mmol/mol)) and 25 patients with “poor” glycemic control 
(HbA1c ≥7%). Random blood sugar levels were measured on 
the day of the test to rule out hypoglycemia.  
Exclusion criteria for all participants included dizziness or 
vertigo during the day of testing or in the past year. 
Screening for dizziness and vertigo was done by questioning 
participants whether they had experienced any recurring 
episodes of dizziness or vertigo in the past year, since vertigo 
is the historical hallmark of a vestibulopathy. Whether 
participants experienced symptoms such as tinnitus, aural 
fullness or hearing loss was also explored. None of the 
participants had experienced any of the above symptoms in 
the past year. 
Table 1.  Clinical, subclinical features and anthropometric measures in control subjects and diabetic patients 
 Control Subjects Diabetic Patients 
Age (years) 
 
Height (m) 
Male 
Female 
 
BMI (Kg/m2) -Total 
Male 
Female 
 
Duration of diabetes (years) 
 
Glycemic measures 
 
Hypoglycemic Drugs 
 
Hypertension (Controlled) 
 
Dizziness in past year 
56.64 ± 5.45 (49.0 – 69.0) 
 
 
1.76 ± 0.05 (1.65 – 1.84) 
1.61 ± 0.05 (1.52 – 1.67) 
 
27.4 ± 4.1 (22.2 – 36.4) 
27.81 ± 4.01 (22.20 – 36.36) 
26.33 ± 4.35 (22.58 – 35.07) 
 
-- 
 
FBG: 98.7 ± 8.5 mg/dl 
 
-- 
 
3 Yes, 26 No 
 
None 
57.0 ± 6.10 (46.0 – 69.0) 
 
 
1.72 ± 0.06 (1.58 – 1.81)** 
1.55 ± 0.06 (1.46 – 1.66)** 
 
30.0 ± 5.3* (21.2– 54.3) 
29.09 ± 3.67 (31.20 – 37.91) 
33.00 ± 7.64 (26.42 – 54.28)* 
 
10.1 ± 8.0 (0.3 – 35.0) 
 
HbA1c: 7.1 ±1.0 % (5.3 – 10.4) 
 
47 Yes 
 
38 Yes, 10 No 
 
None 
Values represent mean ± SD and (Range of data) 
* P-value < 0.05; ** P-value < 0.01 for differences between control and diabetic mean values with Student t-test 
Controls (Male: n = 20, Female: n = 9); Diabetics (Male: n = 34, Female: n = 13) 
FBG: Fasting blood glucose; HbA1c: Glycated hemoglobin 
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Inclusion criteria for the diabetic patients are the absence 
of diabetic retinopathy and peripheral neuropathy to rule out 
any complications in the visual or proprioceptive system that 
may be confounding factors to our current findings. 
Neurological examinations in the diabetic patients were 
performed by medical/health professionals at the medical 
center. All the diabetic patients have been routinely to the 
eye clinic at the Gulf Diabetes Specialist Center where 
ophthalmologists carried out a comprehensive eye exam; a 
complete report was then included in the patients’ records. In 
this study, all cases had their eye exam done within the past 
year and showed no evidence of retinopathy. 
All patients in this study were tested for peripheral 
neuropathy in the clinic before joining the study as part of the 
inclusion criteria. Patients with a diagnosis or history of any 
form of diabetic neuropathy or on any form of treatment 
were excluded from the study. However, all cases had foot 
examination by the endocrinologist. The feet were inspected 
for any skin breaks, red or callused areas, decreased or absent 
pedal pulses, and delayed capillary refilling, bony 
deformities, and protective sensation. Protective sensation 
was assessed by the 5.07 Semmes-Weinstein (10-g) nylon 
mono filament test (SWME). The monofilament was applied 
to a non-callused area on the dorsum of the first toe, and the 
SWME threshold was defined as the total number of times 
the application of the 10-g monofilament was not perceived 
by the subject.  
Also the vibration testing was done by the 128-Hz tuning 
fork applied to the bony prominence situated at the dorsum 
of the first toe. The patient was asked to report the perception 
of both the start of the vibration sensation and the cessation 
of vibration, and the vibration testing threshold was defined 
as the total number of times the application of the vibrating 
tuning fork was not felt. Ankle reflexes were obtained at both 
ankles. With the patient sitting or lying, the examiner gently 
dorsiflexed the foot and struck the Achilles tendon briskly 
with the reflex hammer. The reflex was scored as 0 (absent 
with reinforcement), 1 (present, decreased), 2 (normal), or 3 
(increased). Superficial pain sensation was conducted with a 
sterile small, disposable, hand-held device used to deliver 
blunt or sharp stimuli (Neurotip) at many sites over the 
plantar aspect of each foot with the stimulus applied once per 
site. Patients were asked to identify a felt sensation as sharp 
or dull. Findings were scored as sharp, dull, or absent for 
each site. No diabetic patient showed any evidence of 
peripheral neuropathy.  
Informed voluntary consent to participate in the study was 
obtained from the subjects before any data collection. The 
research ethics committee at the Arabian Gulf University 
(AGU) and the Gulf Diabetes Specialist Center in Bahrain 
approved the research protocol, which also complied with 
the ethical standards of the Helsinki declaration. 
Computerized rod and frame test (CRFT)  
The CRFT was used to assess verticality perception and 
visual dependence for spatial orientation for all subjects. The 
detailed description of the materials and procedures of the 
test are presented in a previous article [16].  
Subjects were presented with a square white frame on a 
plain black background. The test comprised 18 presentations, 
the first two being for instruction and not included in the 
analysis. The first presentation in each test always contained 
the upright (untilted) frame, and the second presentation 
employed a tilted frame and was used to confirm that the 
subject understood the task. For the remaining 16 
presentations, SVV was measured in four visual contexts: no 
visual reference (SVV); the frame untilted and aligned with 
the true gravitational vertical (0°, Frame0); the frame tilted 
clockwise (+18°, Frame+18), or tilted counter-clockwise 
(-18°, Frame-18) with respect to the vertical. The parameters 
analysed in this study were the mean values for the absolute 
SVV error for each individual in the absence and presence of 
a frame (either erect or tilted clockwise or 
counter-clockwise).  
Another parameter investigated was the asymmetry of the 
errors induced by the tilted frame around the untilted frame 
error. The asymmetry of the errors induced by the tilted 
frame around the untilted frame error was investigated by 
deriving an asymmetry index (δ°) from the signed data. For 
each individual this was calculated by summing the 
differences between the mean signed errors in the tilted 
frame conditions (Frame+18, Frame-18) and the mean signed 
error in the Frame0 condition. 
Visual dependence asymmetry index (δ°) = (Frame+18 – 
Frame0) + (Frame-18 – Frame0) 
 
 
A                                          B                                              C 
Figure 1.  Presentations of “rod” and frame during testing. Order of presentation randomly assigned by computer 
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A symmetrical response to the frame tilt is indicated by a 
value of δ close to 0. Larger values indicate increased 
asymmetry, with the sign showing the direction of the skew. 
The direction of the skew is important for each individual, 
but when assessing group data there is a risk of positive and 
negative values cancelling, and so the absolute value of δ 
was used in the analysis of the results. 
Statistical analysis  
Data were analysed using the Statistical Package for 
Social Sciences (SPSS 15) software. All data passed 
normality by the Kolmogorov and Smirnov test. Parametric 
statistics were used since all data followed a normal 
distribution. Analysis of variance was used to compare mean 
errors between groups or between frame contexts; post-hoc 
analysis was performed when p < 0.05. For all tests, the 
significance level was fixed at 0.05. Data from asymptomatic 
subjects served as control values. When included in the 
analysis, the reference range for error distributions in this 
control group was calculated as mean +2SD of these data. 
3. Results  
Participants  
There were no significant differences between the three 
groups with regards to age or body mass index (BMI). 
Comparison of the two diabetic groups found no significant 
difference in the duration of the disease however there was a 
significantly higher mean HbA1c level in the group with 
“poor” glycemic control (Table 1). The controls had a 
normal mean fasting glucose level (measured on the day of 
the test) of 98.6 ± 8.5 mg/dl (Range: 81.0 mg/dl – 105.0 
mg/dl). 
Perception of Visual Vertical 
SVV/ Visual Dependence Errors and Glycemic Control  
In the absence of cues given by a surrounding frame, all 
control subjects and most diabetic subjects from both 
subgroups fell within a range considered normal for SVV (< 
2°). The difference between the mean values was less than 
0.5 degrees in each case (less than one mouse click, Table 1). 
When the groups were presented with a visual frame tilted by 
18 degrees in either a clockwise or counter clockwise 
direction their positioning errors increased significantly in 
comparison to the frameless presentations (P < 0.001 in all 
cases). For all groups, a combined Frame 18 value (Comb18°) 
was averaged from the absolute values of Frame+18 and 
Frame-18 since they did not differ significantly (P > 0.05 for 
all cases). 
The distribution of errors for all groups is presented in Fig. 
2A. The difference between mean Comb18° errors of controls 
and “good” glycemic control diabetics approached 1 degree 
(2 mouse clicks) with analysis showing a significant 
difference (P = 0.01). The difference between the healthy 
controls and “poor” glycemic control group was less than 
0.5° (1 mouse click). There was no significant difference 
between the means of the two diabetic subgroups (P > 0.05).  
There were also differences in the numbers of subjects 
falling above the reference range for Comb18° errors 
calculated from control data (mean + 2SD = 3.3°). None of 
the control subjects exceeded this value however only 2 
diabetics with “poor” glycemic control (7.7%) and 8 
diabetics with “good” glycemic control (33.3%) exceeded it 
(“poor” and “good” glycemic control: Fisher’s test; P = 0.03). 
The mean Comb18° error for these 8 subjects with “good” 
glycemic control falling into this category was 4.57 ± 0.98°. 
Visual Dependence Asymmetry and Glycemic Control  
The differences in the asymmetry index between the three 
groups were significant (One-way ANOVA: P < 0.0001). 
Healthy controls had a significantly smaller mean 
asymmetry index in comparison to each of the diabetic 
groups (Table 1). The asymmetry index in the “good” 
glycemic control group was significantly larger than the 
“poor” group. There was a significant positive correlation  
(r = 0.55, P = 0.007) between the asymmetry index and 
Comb18 errors in the “good” glycemic group but this was not 
the case for either the healthy subjects (r = 0.31, P = 0.10) 
nor the “poor” glycemic control group (r = 0.30, P = 0.15). 
HbA1c Association with Some Parameters 
In the “good” glycemic group, %HbA1c was not associated 
with the duration of diagnosis of the disease (r = 0.33, P = 
0.12). As for the verticality parameters, % HbA1c did not 
correlate with the asymmetry index (r = 0.36; P = 0.10) but 
was significantly associated with the level of visual 
dependence represented by the Comb18 errors (r = 0.45; P = 
0.04; n =22). For the “poor” glycemic control, % HbA1c  
correlated positively with the  duration of the disease ( r = 
0.51, P = 0.01), indicating decreased glycemic control with 
longer duration of diabetes exposure (Figure 3). Similar to 
the other diabetic group, % HbA1c  did not correlate with the 
asymmetry index (r = 0.22; P = 0.29) but was significantly 
associated SVV errors without a frame (r = 0.41; P = 0.04). 
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Table 2.  Comparison of demographics, subclinical features and subjective visual vertical data parameters between healthy control subjects and diabetic 
patients with “good” and “poor” glycemic control 
 
Control 
(n =29) 
“Good” Glycemic 
Control 
(n = 22) 
“Poor” Glycemic 
Control 
(n=25) 
Difference 
across groups 
(P-value) 
Post-hoc analysis (P-value) 
Control vs 
“Good” 
Glycemic 
Control 
Control vs 
“Poor” Glycemic 
Control 
“Good” vs 
“Poor” 
Glycemic 
Control 
Age 
 
 
BMI (kg/m2) 
 
 
Years with 
diabetes 
 
HbA1c (%) 
 
 
Abs SVV (°) 
 
 
Comb 18(°) 
 
 
Asymmetry 
Index (°) 
56.6 ± 5.5 
(49.0 – 69.0) 
 
27.4 ± 4.1 
(22.2 – 36.4) 
 
-- 
 
 
-- 
 
 
0.90 ± 0.44 
(0.13 – 1.88) 
 
1.69 ± 0.79 
(0.38 – 3.19) 
 
0.90 ± 0.92 
(0.00 – 3.13) 
58.0 ± 6.22 
(47.5 – 68.0) 
 
30.6 ± 5.9 
(24.5 – 54.3) 
 
8.9 ± 10.1 
(0.3 – 35.0) 
 
6.3 ± 0.4 
(5.3 – 6.9) 
 
1.13 ± 0.54 
(0.38 – 2.37) 
 
2.73 ± 1.64 
(0.94 – 6.31) 
 
2.70 ± 1.51 
(0.13 – 5.75) 
56.2 ± 6.0 
(46.0 – 69.0) 
 
29.6 ±  4.6 
(21.2 – 43.2) 
 
11.2 ± 5.6 
(1.0 – 23.0) 
 
7.9 ± 0.8 
(7.0 – 10.4) 
 
1.05 ± 0.62 
(0.38 – 2.38) 
 
2.13 ± 1.11 
(0.56 – 5.50) 
 
1.68 ± 1.12 
(0.38 – 5.25) 
0.56 
 
 
0.48 
 
 
N/A 
 
 
N/A 
 
 
0.30 
 
 
0.01 
 
 
< 0.0001 
 
-- 
 
 
-- 
 
 
-- 
 
 
-- 
 
 
-- 
 
 
0.01 
 
 
< 0.0001 
 
-- 
 
 
-- 
 
 
-- 
 
 
-- 
 
 
-- 
 
 
0.10 
 
 
0.008 
 
-- 
 
 
-- 
 
 
0.34 
 
 
< 0.0001 
 
 
-- 
 
 
0.16 
 
 
0.01 
 
Values given are mean ± SD and (Range of data). Student t-test was used for comparison between the two diabetic groups and one-way ANOVA for comparison of 
controls and both diabetic groups. SVV indicates unsigned positional errors (in degrees) for vertical when no frame is present. “Comb18°” refers to the mean of 
unsigned errors generated when the tilted frame was present (data for both tilted frame conditions have been combined). N/A: not applicable; bold indicates P < 0.05 
 
 
           
A                                                           B 
Figure 2.  A. Distribution of the positioning errors to vertical.  B. Box and Whisker plots of the data with median and inter-quartile range of unsigned 
deviation errors for both controls and both diabetic groups with a tilted surrounding frame (Comb 18°). Diabetics: “Good” glycemic control (HbA1c < 7%); 
“Poor” glycemic control (HbA1c ≥ 7%) 
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Figure 3.  Relationship between duration of diabetes and plasma glucose levels as measured by % glycated haemoglobin (HbA1c) in “poor” glycemic group 
 
4. Discussion 
Our previous results suggested that vestibular otolithic 
function may be affected in diabetic patients as evidenced by 
differences from healthy controls in magnitude and 
asymmetry of visual dependence for spatial orientation on 
the CRFT [13]. In the current study, we investigated whether 
glycemic control (measured by HbA1c levels) might predict 
visual dependence for spatial orientation in patients with 
Type 2 diabetes, relying on two parameter of verticality 
perception: the absolute (unsigned) deviation error and the 
asymmetry index. The cut-off HbA1c value of 7% was used 
to assign patients to the two groups of diabetics with 
differing glycemic control; one could argue that including 
two diabetic groups comprised of patients with widely 
separate HbA1c levels, such as 7% or less and 9% or greater 
may have been more discriminative, however the rationale 
for using a cut-off of HbA1c of 7% is because it is the 
recommended target of diabetes management and sustained 
glycemic control by many Diabetes Associations worldwide 
[17, 18]. 
Results point to increased level of visual dependence even 
in asymptomatic diabetics with glycemic control within the 
recommended target of HbA1c < 7.0% (53 mmol/mol). The 
greater deviation errors when a conflicting visual 
surrounding was introduced provided evidence of greater 
visual dependence in each of the diabetic groups compared 
to the healthy controls. The greater asymmetry index in each 
of the diabetic groups than healthy controls may reflect 
alteration of vestibular input by the disease processes of 
diabetes. This is probable as most diseases of the inner ear or 
vestibular nerve are destructive in nature, decreasing input 
from the ears, and the disease processes of diabetes are not 
expected to affect vestibular function bilaterally to the same 
extent.  
Even though there was no significant difference in 
deviation errors (Comb 18°) between the diabetic groups, 
patients with “poor” glycemic control were paradoxically 
less asymmetrically visually dependent than the “good” 
glycemic diabetics on the CRFT. Such results may indicate 
that in the diabetic patients with “poor” glycemic control, the 
central compensatory mechanisms of vestibular tone 
imbalance may have already been primed in response to the 
deleterious effects of sustained chronic hyperglycemia on 
both vestibular organs. It is interesting that in the “poor” 
glycemic group, HbA1c levels correlated positively with the 
duration of the disease, indicating worse glycemic control 
and sustained hyperglycemia with the progression of the 
disease. Such sustained chronic hyperglycemia is known to 
negatively affect the vascular endothelium and is correlated 
with many diabetes mellitus-related microvascular 
complications [19], some of which may be vestibular 
microangiopathy. 
Overall, diabetics within the recommended target of 
HbA1c < 7.0% (53 mmol/mol) processed verticality as 
inefficiently as diabetics above the recommended range of 
HbA1c during visuo-vestibular conflicts. However, all of the 
patients exhibiting combined errors above the reference 
range had HbA1c levels between 6 and 8.1%. Therefore it is 
possible that those in the “good” glycemic control group (or 
those with low “poor” values), have vestibular damage due 
to glucose fluctuations resulting from interprandial glucose 
decrements followed by postprandial hyperglycemia, which 
is highly prevalent throughout the day in Type 2 diabetic 
y = 0.0751x + 7.0199 
R² = 0.2561 
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patients with HbA1c levels well below 7.0% [20]. These 
acute glucose fluctuations would have more deleterious 
effects than sustained hyperglycemia in the development of 
diabetic complications as both upward (postprandial glucose 
increments) and downward (interprandial glucose 
decrements) changes activate oxidative stress [21-26].   
With asymmetrical vestibular damage, the resultant 
aberrant bilateral otolithic inputs to the vestibular nuclei of 
patients with diabetes may not be as effective as those of 
healthy controls in counteracting the effects of the 
conflicting visual illusion produced by the tilted frame on 
SVV perception. This would lead to greater difficulty with 
visuo-vestibular integration centrally in the brain. The 
discrepancy between the two diabetic groups in vestibular 
asymmetry, along with the association between visual 
dependence and vestibular asymmetry in diabetics with 
“good” glycemic control, suggests different compensatory 
mechanisms to recalibrate vestibular input for asymmetry 
reduction in the groups. Additionally, the relatively weak but 
significant association in both groups between HbA1c and 
SVV (frameless or within a tilted frame) indicates that HbA1c 
levels cannot fully predict diabetic complications in the 
vestibule. As a result, other glycemic factors either affecting 
vestibular symmetry or central compensatory mechanisms 
may be involved. 
5. Limitations and Conclusions  
A major limitation of this study is that the dysfunction of 
SVV and increased visual dependence may not be 
necessarily caused solely by vestibular imbalance since SVV 
is a higher brain function. Without doubt, brain areas 
involved in SVV do utilize vestibular and visual inputs, but it 
is also possible that the diabetic patients may well have had 
vascular complications in the brain areas involved in SVV 
integration. Additionally, vestibular tests that may indicate 
any subclinical vestibular symptoms such as nystagmus 
which represents the physical exam hallmark of vertigo and 
vestibulopathy were not performed on the diabetic patients.  
Another limitation is ignoring to consider participants’ 
blood pressure status, an important clinical factor that is 
evidently different between the control and diabetic group, 
with 81% of the diabetic patients having controlled 
hypertension, and only 10% in the control group. However, 
results of a previous study on cochlear function in 
hypertensive subjects suggested that patients with systemic 
arterial hypertension may have cochlear dysfunction 
associated hypertension but without clear evidence of 
vestibular dysfunction [27].  
Despite of these limitations, our study has demonstrated 
that the visual dependence asymmetry index is a more 
sensitive indicator than absolute errors of differences 
between the two diabetic groups, since CRFT failed to 
distinguish the level of visual dependence (absolute errors) 
between the patient groups with diabetes. Because 
positioning errors above the reference range were found in 
diabetics who had a mean HbA1c of 6.75%, it seems that even 
diabetics with glycemic control within the recommended 
range or slightly above may be vulnerable during 
visuo-vestibular conflict situations due to vestibular 
asymmetry. This asymmetry of responses may cause 
difficulty in maintaining upright orientation in diabetic 
patients, because any unneeded adjustment in posture by 
subjects who may misinterpret any tilted or swaying 
references as tilting or swaying of their own bodies may 
cause loss of their balance [28].  
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